Andersons pediatric cardiology 299
Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (60.92 KB, 3 trang )
ofthecardiacoutflowtract.BaltimoreWashingtonInfantStudyGroup.Epidemiology.
1998;9:95–98.
64.GreggNM.Congenitalcataractfollowing
Germanmeaslesinthemother.1941.AustNZJ
Ophthalmol.1991;19:267–276.
65.PradatP.Epidemiologyofmajorcongenitalheart
defectsinSweden,1981-1986.JEpidemiol
CommunityHealth.1992;46:211–215.
66.WallerDK,ShawGM,RasmussenSA,etal.
Prepregnancyobesityasariskfactorfor
structuralbirthdefects.ArchPediatrAdolesc
Med.2007;161:745–750.
67.KellyTE,EdwardsP,ReinM,MillerJQ,
DreifussFE.Teratogenicityofanticonvulsant
drugs.II:aprospectivestudy.AmJMedGenet.
1984;19:435–443.
68.HansonJW.Teratogenupdate:fetalhydantoin
effects.Teratology.1986;33:349–353.
69.EricsonA,KallenBA.Nonsteroidalantiinflammatorydrugsinearlypregnancy.Reprod
Toxicol.2001;15:371–375.
70.Hernandez-DiazS,WerlerMM,WalkerAM,
MitchellAA.Folicacidantagonistsduring
pregnancyandtheriskofbirthdefects.NEnglJ
Med.2000;343:1608–1614.
71.SmithellsRW,NewmanCG.Recognitionof
thalidomidedefects.JMedGenet.1992;29:716–
723.
72.CzeizelAE,RockenbauerM,SorensenHT,
OlsenJ.Theteratogenicriskoftrimethoprimsulfonamides:apopulationbasedcase-control
study.ReprodToxicol.2001;15:637–646.
73.DaiWS,HsuMA,ItriLM.Safetyofpregnancy
afterdiscontinuationofisotretinoin.Arch
Dermatol.1989;125:362–365.
74.GeigerJM,BaudinM,SauratJH.Teratogenic
riskwithetretinateandacitretintreatment.
Dermatology.1994;189:109–116.
75.TikkanenJ,HeinonenOP.Riskfactorsforconal
malformationsoftheheart.EurJEpidemiol.
1992;8:48–57.
76.ShawGM,NelsonV,IovannisciDM,Finnell
RH,LammerEJ.Maternaloccupational
chemicalexposuresandbiotransformation
genotypesasriskfactorsforselectedcongenital
anomalies.AmJEpidemiol.2003;157:475–484.
77.TikkanenJ,HeinonenOP.Riskfactorsfor
coarctationoftheaorta.Teratology.
1993;47:565–572.
78.Correa-VillasenorA,FerenczC,BoughmanJA,
NeillCA.Totalanomalouspulmonaryvenous
return:familialandenvironmentalfactors.The
Baltimore-WashingtonInfantStudyGroup.
Teratology.1991;44:415–428.
79.Correa-VillasenorA,FerenczC,NeillCA,
WilsonPD,BoughmanJA.Ebstein's
malformationofthetricuspidvalve:geneticand
environmentalfactors.TheBaltimoreWashingtonInfantStudyGroup.Teratology.
1994;50:137–147.
80.Deletedinreview.
81.DigilioMC,MarinoB,CiciniMP,etal.Riskof
congenitalheartdefectsinrelativesofpatients
withatrioventricularcanal.AmJDisChild.
1993;147:1295–1297.
82.EmanuelR,NicholsJ,AndersJM,MooresEC,
SomervilleJ.Atrioventriculardefects–astudyof
92families.BrHeartJ.1968;30:645–653.
83.NoraJJ,NoraAH.Updateoncounselingthe
familywithafirst-degreerelativewitha
congenitalheartdefect.AmJMedGenet.
1988;29:137–142.
84.Sanchez-CascosA.Therecurrenceriskin
congenitalheartdisease.EurJCardiol.
1978;7:197–210.
85.SheffieldVC,PierpontME,NishimuraD,etal.
Identificationofacomplexcongenitalheart
defectsusceptibilitylocusbyusingDNA
poolingandsharedsegmentanalysis.HumMol
Genet.1997;6:117–121.
